Teal Ventures is a venture capital firm established in 2018 and located in San Diego, California. The firm specializes in investing in early-stage companies that are innovating in health technology, data science, artificial intelligence, and machine learning. Teal Ventures partners with entrepreneurs to bring breakthrough health tech innovations to life, providing hands-on support and expertise to help founders advance their visions. The firm focuses on companies that disrupt traditional markets, with a notable preference for women-founded and women-led businesses. By understanding the trends and fundamentals of the health tech sector, Teal Ventures aims to foster collaboration with innovative thinkers and contribute to the growth of transformative solutions in healthcare.
Cooler Heads develops a portable scalp cooling system designed for chemotherapy patients. It transforms life for people diagnosed with cancer by giving them more control over how they experience the side effects of treatment. Its product Amma™ offers people with cancer a choice in whether they lose their hair during chemotherapy.
Nudj Health
Series A in 2022
Nudj Health is currently operating in stealth mode.
Cooler Heads develops a portable scalp cooling system designed for chemotherapy patients. It transforms life for people diagnosed with cancer by giving them more control over how they experience the side effects of treatment. Its product Amma™ offers people with cancer a choice in whether they lose their hair during chemotherapy.
PRR offers an online educational program presented in collaboration with the University of California San Diego School of Medicine faculty to give doctors career options and help solve the nation's growing physician shortage.
The Trials.ai Smart Protocol system leverages artificial intelligence to efficiently navigate research teams in designing clinical trials that enable pharma, biotech and device companies to get treatments to patients faster. Trial sponsors spend $65B every year on clinical trials and 45% of those trials fail because they are poorly designed. These failures equate to billions of dollars in lost opportunity for trial sponsors every year - but more importantly, patients don't have time to wait for us to get it right. In the digital age, humans cannot physically read and digest every bit of information relevant to a given decision. In addition, almost every organization has what is called 'dark' or 'siloed' data – valuable data that is not being used, or that organizations don’t know they have at their disposal. It is estimated that as much as 90% of the data within a given organization is dark or siloed. As a result, pharmaceutical companies are making important decisions with incomplete information. ENTER TRIALS.AI - we are on a mission to get effective treatments to patients faster by using artificial intelligence to optimize clinical trial designs for speed and success. Unlike the current service models out there, we use smart technology to harness vast amounts of data that no human can process – then offer unique insights across therapeutic areas to trial sponsors. Using our codified clinical trials database, we are able to unlock information, derive insights and make recommendations to trial sponsors on how to best design & optimize their trial protocols. Based in San Diego, California, Trials.ai launched by Kim Walpole in 2016.
Founded in 2016, NeuraLace is a technology company with a focus on medical innovations. The company is developing a non-invasive interface, bridging the gap between technology and neurology, to deliver sustainable chronic pain relief at scale.
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.